Related Experiment Video
Updated: May 10, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
A+KIDS, a web-based antipsychotic registry for North Carolina youths: an alternative to prior authorization
Insights
The Antipsychotics-Keeping It Documented for Safety (A+KIDS) registry successfully enrolled thousands of children, improving antipsychotic safety monitoring. This initiative provides valuable clinical data beyond standard prescription claims.
Area of Science:
- Pediatric pharmacology
- Public health initiatives
- Child and adolescent psychiatry
Background:
- Rising antipsychotic use in U.S. children necessitates improved safety monitoring.
- Current safety-monitoring guideline compliance is notably low.
- The North Carolina Division of Medical Assistance created the A+KIDS registry to address these issues.
Purpose of the Study:
- Establish a functional web-based safety registry for pediatric antipsychotic use.
- Collect and analyze clinical data from the A+KIDS registry.
- Evaluate the effectiveness of the A+KIDS registry in enhancing safety.
Main Methods:
- Prescribers of antipsychotics for children aged 12 and under were surveyed starting April 2011.
- Registry data was linked with North Carolina Medicaid prescription claims for comprehensive analysis.
- Prescriber types and registration volumes were examined.
Main Results:
- Within six months, 730 prescribers registered 5,532 patients, with 19% under age seven.
- By month six, 72% of all antipsychotic fills were registered.
- Top diagnoses included mood disorders, autism spectrum disorders, and disruptive behavior disorders, with aggression as the primary target symptom.
Conclusions:
- The A+KIDS registry demonstrates rapid adoption and success in its initial phase.
- The registry yields crucial clinical insights not obtainable from claims data alone.
- Future work will focus on detailed antipsychotic utilization analysis and safety enhancements.
Objective:
The rise in use of antipsychotics among U.S. children is well documented. Compliance rates with current safety-monitoring guidelines are low. In response, the North Carolina Division of Medical Assistance established the Antipsychotics-Keeping It Documented for Safety (A+KIDS) registry. The initial objectives of the project were to successfully establish a Web-based safety registry and to obtain and evaluate clinical information derived from the registry.
Methods:
In April 2011, A+KIDS began asking prescribers of antipsychotics for children age 12 and under to respond to a set of questions regarding dose, indication, and usage history. Antipsychotic registrations were examined by linking North Carolina Medicaid prescription claims to registry entries. Prescribers were classified into different types, and the number of patients and registrations per prescriber were examined.
Results:
In the initial six months, 730 prescribers registered 5,532 patients, 19% below age seven. By month 6 of the registry, 72% of all fills were registered with the program. Top diagnosis groups for registry patients were unspecified mood disorders, autism spectrum disorders, and disruptive behavior disorders. Top target symptoms were aggression (48%), irritability (19%), and impulsivity (11%). Psychosis accounted for 5% of the target symptoms. Twenty-eight percent of children were receiving no form of psychotherapy. Twenty-five percent of all A+KIDS prescribers were responsible for 81% of the registrations.
Conclusions:
The A+KIDS registry initiative has been successful, as measured by rapid uptake, and is providing clinical information not available from claims data alone. Future efforts will allow for detailed examinations of antipsychotic utilization and further safety improvement.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Dosing: Infants and Children

